Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature-Reference-Cited by-同舟云学术

Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature

Published:2019-12-15 Issue:2 Volume:188 Page:338-340
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Elessa Dikélélé¹²^ORCID,Talbot Alexis¹²,Lombion Naëlle¹²,Harel Stéphanie¹²,Galicier Lionel²³^ORCID,Veyradier Agnès²⁴⁵,Joly Bérangère²⁴⁵,Andreoli Annalisa⁶,Rigaudeau Sophie⁷,Azoulay Élie²⁸,Coppo Paul⁴⁹,Royer Bruno¹²,Arnulf Bertrand¹²^ORCID

Affiliation:

1. Department of Immunohematology Hôpital Saint‐Louis Assistance Publique – Hôpitaux de Paris ParisFrance

2. University Paris Diderot Sorbonne Paris Cité Paris France

3. Department of Clinical Immunology Hôpital Saint‐Louis Assistance Publique – Hôpitaux de Paris Paris France

4. National Reference Center for Thrombotic Microangiopathy Hôpital Saint‐Antoine Assistance Publique ‒ Hôpitaux de Paris Paris France

5. Department of Biological Hematology Hôpital Lariboisière Assistance Publique ‒ Hôpitaux de Paris Paris France

6. Department of Clinical Hematology Centre Hospitalier Victor Dupouy Argenteuil France

7. Department of Clinical Hematology Centre Hospitalier Versailles Le Chesnay France

8. Department of Intensive Care Medicine Hôpital Saint‐Louis Assistance Publique – Hôpitaux de Paris Paris France

9. Department of Clinical Hematology Hôpital Saint Antoine Assistance Publique ‒ Hôpitaux de Paris Paris France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16333

Reference12 articles.

1. Drug-induced thrombotic microangiopathy: a systematic review of published reports

2. Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosis

3. Thrombotic thrombocytopenic purpura in a patient with lenalidomide-responsive multiple myeloma

4. Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience

5. VEGF Inhibition and Renal Thrombotic Microangiopathy

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Nexus: Lenalidomide-Associated Thrombotic Thrombocytopenic Purpura;Cureus;2024-06-23

2. Drug‐induced thrombotic thrombocytopenic purpura: A systematic review and review of European and North American pharmacovigilance data;British Journal of Haematology;2022-12-07

3. Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature;Frontiers in Medicine;2022-05-17

4. Carfilzomib-induced thrombotic microangiopathy is underestimated in clinical practice: A report of five patients and literature review;Leukemia & Lymphoma;2022-04-03

5. The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer;Healthcare;2022-03-16